CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B952. A total of 3 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363 | +21.8% | 13,200 | +50.0% | 0.00% | – |
| Q2 2023 | $298 | +56.8% | 8,800 | +66.0% | 0.00% | – |
| Q1 2023 | $190 | -79.2% | 5,300 | -74.1% | 0.00% | -100.0% |
| Q4 2022 | $913 | -99.7% | 20,500 | +81.4% | 0.00% | – |
| Q3 2022 | $317,000 | -86.5% | 11,300 | -87.1% | 0.00% | -100.0% |
| Q2 2022 | $2,356,000 | +8.3% | 87,400 | +36.8% | 0.00% | +50.0% |
| Q1 2022 | $2,176,000 | +871.4% | 63,900 | +1001.7% | 0.00% | – |
| Q4 2021 | $224,000 | +3633.3% | 5,800 | +2800.0% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -94.5% | 200 | +277.4% | 0.00% | – |
| Q1 2021 | $109,000 | +22.5% | 53 | +3.9% | 0.00% | – |
| Q4 2020 | $89,000 | -87.3% | 51 | -89.2% | 0.00% | -100.0% |
| Q3 2020 | $701,000 | -55.7% | 473 | -61.2% | 0.00% | -66.7% |
| Q2 2020 | $1,584,000 | +4425.7% | 1,219 | +477.7% | 0.00% | – |
| Q1 2020 | $35,000 | +250.0% | 211 | +368.9% | 0.00% | – |
| Q4 2019 | $10,000 | -44.4% | 45 | -48.3% | 0.00% | – |
| Q3 2019 | $18,000 | -35.7% | 87 | -17.9% | 0.00% | – |
| Q2 2019 | $28,000 | – | 106 | +5200.0% | 0.00% | – |
| Q1 2019 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 1,219 | $1,584,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 21,600 | $281,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |